These findings suggest that the downregulation of HSPA12A expression was associated with poor prognosis in human RCC, which could be attributed to the negative regulatory effect of HSPA12A on RCC cell migration. This evidence concerns the gene HSPA12A and renal cell adenocarcinoma.